Retatrutide prescriptions likely wont be available prior to 2025 to 2027 because the medication is being studied in a Phase 3 clinical trial that wont end until 2025 or 2026
Monitor for symptoms of over-replacement, such as anxiety, rapid heart rate, insomnia , or unintentional weight loss beyond expected tirzepatide effects
In 2012, a once-weekly version called Bydureon was approved
55,56 However, it should be noted that these findings should not be extrapolated to GLP-1RAs that were approved by drug regulatory agencies only recently (eg, dulaglutide and semaglutide) and for which similar RWS are not yet published
She has done all my work and I have never felt so confident around my skin until now
Semaglutide may have particular benefits when used in patients with T2DM who are overweight